Cargando…

Costs vs benefits of tackling COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196038/
https://www.ncbi.nlm.nih.gov/pubmed/32382246
http://dx.doi.org/10.1007/s40274-020-6760-2
_version_ 1783528643032514560
collection PubMed
description
format Online
Article
Text
id pubmed-7196038
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71960382020-05-04 Costs vs benefits of tackling COVID-19 PharmacoEcon Outcomes News Comment Springer International Publishing 2020-05-02 2020 /pmc/articles/PMC7196038/ /pubmed/32382246 http://dx.doi.org/10.1007/s40274-020-6760-2 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Costs vs benefits of tackling COVID-19
title Costs vs benefits of tackling COVID-19
title_full Costs vs benefits of tackling COVID-19
title_fullStr Costs vs benefits of tackling COVID-19
title_full_unstemmed Costs vs benefits of tackling COVID-19
title_short Costs vs benefits of tackling COVID-19
title_sort costs vs benefits of tackling covid-19
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196038/
https://www.ncbi.nlm.nih.gov/pubmed/32382246
http://dx.doi.org/10.1007/s40274-020-6760-2